Position in ELAN
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$3,410,527
-$725,218 QoQ
Shares Held
142,521
-22.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 16.42284294946008.ToString("F0")%
Shared 0.ToString("F0")%
None 83.57715705053992.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Phocas Financial Corp. holds $23,598,730 across 5 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,002,664 | $12,463,113 | |
| 2 | ELAN |
Elanco Animal Health Inc
This page
|
142,521 | $3,410,527 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
63,413 | $3,277,817 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
|
114,413 | $2,585,733 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
195,540 | $1,861,540 |
All Filings in ELAN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,410,527 | 142,521 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $4,135,745 | 182,755 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $4,429,974 | 219,959 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,076,454 | 215,438 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,261,763 | 215,406 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,756,526 | 227,624 | Shares | Sole | 2025-03-05 | |
| 2024-09-30 | $3,372,104 | 229,551 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $5,975,535 | 414,105 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $6,869,085 | 421,934 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $3,857,148 | 258,869 | Shares | Sole | 2024-01-30 | |
| No filing history on record for this holder in this stock. | ||||||